Search

Search Results
Results 11 - 20 of 46 for Pulmonary Embolism
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooke (drospirenone 3 mg and ethinylestradiol 20 micrograms) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brooklynn (drospirenone 3 mg and ethinylestradiol 30 micrograms) intended for persons living in Australia.
  • Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Brenda-35 ED intended for persons living in Australia.
  • Drug - 28 Jun 2022
    Consumer Medicine Information (CMI) about Lonsurf (Trifluridine/Tipiracil Hydrochloride) intended for persons living in Australia.
  • Drug - 5 Dec 2022
    Consumer Medicine Information (CMI) about Zeldox IM (ziprasidone) intended for persons living in Australia.
  • Drug - 21 May 2024
    Consumer Medicine Information (CMI) about Premarin (Conjugated estrogens Tablets) intended for persons living in Australia.
  • Drug - 6 May 2024
    Consumer Medicine Information (CMI) about Vagifem Low (Estradiol) intended for persons living in Australia.
  • Drug - 30 Apr 2024
    Consumer Medicine Information (CMI) about DBL Cisplatin Injection (cisplatin) intended for persons living in Australia.
  • Drug - 26 Mar 2024
    Consumer Medicine Information (CMI) about Cresemba intended for persons living in Australia.
  • Drug - 16 Feb 2024
    Consumer Medicine Information (CMI) about Lynparza Tablets intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.